Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy?

Mesenchymal stromal cells (MSCs) harbor great therapeutic potential for numerous diseases. From early clinical trials, success and failure analysis, bench-to-bedside and back-to-bench approaches, there has been a great gain in knowledge, still leaving a number of questions to be answered regarding o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moll, Guido (VerfasserIn) , Bieback, Karen (VerfasserIn)
Dokumenttyp: Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 12 November 2016
In: Biobanking and cryopreservation of stem cells
Year: 2016, Pages: 77-98
DOI:10.1007/978-3-319-45457-3_7
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/978-3-319-45457-3_7
Verlag, Volltext: https://doi.org/10.1007/978-3-319-45457-3_7
Volltext
Verfasserangaben:Guido Moll, Sven Geißler, Rusan Catar, Lech Ignatowicz, Martin J. Hoogduijn, Dirk Strunk, Karen Bieback, Olle Ringdén

MARC

LEADER 00000caa a2200000 c 4500
001 158761944X
003 DE-627
005 20230427034236.0
007 cr uuu---uuuuu
008 190213s2016 xx |||||o 00| ||eng c
024 7 |a 10.1007/978-3-319-45457-3_7  |2 doi 
035 |a (DE-627)158761944X 
035 |a (DE-576)51761944X 
035 |a (DE-599)BSZ51761944X 
035 |a (OCoLC)1341038065 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Moll, Guido  |e VerfasserIn  |0 (DE-588)1177937549  |0 (DE-627)1049057120  |0 (DE-576)517619563  |4 aut 
245 1 0 |a Cryopreserved or fresh mesenchymal stromal cells  |b only a matter of taste or key to unleash the full clinical potential of MSC therapy?  |c Guido Moll, Sven Geißler, Rusan Catar, Lech Ignatowicz, Martin J. Hoogduijn, Dirk Strunk, Karen Bieback, Olle Ringdén 
264 1 |c 12 November 2016 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.02.2019 
500 |a First Online 12 November 2016 
520 |a Mesenchymal stromal cells (MSCs) harbor great therapeutic potential for numerous diseases. From early clinical trials, success and failure analysis, bench-to-bedside and back-to-bench approaches, there has been a great gain in knowledge, still leaving a number of questions to be answered regarding optimal manufacturing and quality of MSCs for clinical application. For treatment of many acute indications, cryobanking may remain a prerequisite, but great uncertainty exists considering the therapeutic value of freshly thawed (thawed) and continuously cultured (fresh) MSCs. The field has seen an explosion of new literature lately, outlining the relevance of the topic. MSCs appear to have compromised immunomodulatory activity directly after thawing for clinical application. This may provide a possible explanation for failure of early clinical trials. It is not clear if and how quickly MSCs recover their full therapeutic activity, and if the “cryo stun effect” is relevant for clinical success. Here, we will share our latest insights into the relevance of these observations for clinical practice that will be discussed in the context of the published literature. We argue that the differences of fresh and thawed MSCs are limited but significant. A key issue in evaluating potency differences is the time point of analysis after thawing. To date, prospective double-blinded randomized clinical studies to evaluate potency of both products are lacking, although recent progress was made with preclinical assessment. We suggest refocusing therapeutic MSC development on potency and safety assays with close resemblance of the clinical reality. 
650 4 |a Cell engraftment 
650 4 |a Cell therapy 
650 4 |a Coagulation 
650 4 |a Complement 
650 4 |a Cryopreservation 
650 4 |a Cryopreservation-induced cell death 
650 4 |a Freeze injury 
650 4 |a Freeze-thawing 
650 4 |a Mesenchymal stromal cell 
650 4 |a T cells 
700 1 |a Bieback, Karen  |d 1972-  |e VerfasserIn  |0 (DE-588)124509991  |0 (DE-627)376254653  |0 (DE-576)294206604  |4 aut 
773 0 8 |i Enthalten in  |t Biobanking and cryopreservation of stem cells  |d Cham : Springer, 2016  |g (2016), Seite 77-98  |h Online-Ressource (XIV, 238 p. 23 illus., 20 illus. in color, online resource)  |w (DE-627)1654791407  |w (DE-576)480949794  |z 9783319454573  |7 nnam  |a Cryopreserved or fresh mesenchymal stromal cells only a matter of taste or key to unleash the full clinical potential of MSC therapy? 
773 1 8 |g year:2016  |g pages:77-98  |g extent:22  |a Cryopreserved or fresh mesenchymal stromal cells only a matter of taste or key to unleash the full clinical potential of MSC therapy? 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-45457-3_7  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1007/978-3-319-45457-3_7  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190213 
993 |a BookComponentPart 
994 |a 2016 
998 |g 124509991  |a Bieback, Karen  |m 124509991:Bieback, Karen  |d 60000  |d 63500  |e 60000PB124509991  |e 63500PB124509991  |k 0/60000/  |k 1/60000/63500/  |p 7 
999 |a KXP-PPN158761944X  |e 3055837983 
BIB |a Y 
JSO |a {"relHost":[{"part":{"year":"2016","extent":"22","pages":"77-98","text":"(2016), Seite 77-98"},"relMultPart":[{"disp":"Advances in experimental medicine and biology","type":{"bibl":"serial","media":"Online-Ressource"},"language":["eng"],"part":{"number_sort":["951"],"number":["volume 951"]},"note":["Gesehen am 30.10.13"],"pubHistory":["1.1967 -"],"dispAlt":"Advances in experimental medicine and biology","title":[{"title_sort":"Advances in experimental medicine and biology","title":"Advances in experimental medicine and biology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2385266-5"],"issn":["2214-8019"],"eki":["543309940"]},"origin":[{"publisher":"Springer ; Springer","dateIssuedDisp":"1967-","dateIssuedKey":"1967","publisherPlace":"[Dordrecht] ; [Heidelberg]"}],"recId":"543309940"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"edited-book"},"disp":"Cryopreserved or fresh mesenchymal stromal cells only a matter of taste or key to unleash the full clinical potential of MSC therapy?Biobanking and cryopreservation of stem cells","recId":"1654791407","person":[{"family":"Karimi-Busheri","role":"edt","display":"Karimi-Busheri, Feridoun","given":"Feridoun"},{"role":"edt","family":"Weinfeld","display":"Weinfeld, Michael","given":"Michael"}],"name":{"displayForm":["edited by Feridoun Karimi-Busheri, Michael Weinfeld"]},"origin":[{"dateIssuedDisp":"2016","publisher":"Springer","publisherPlace":"Cham","dateIssuedKey":"2016"}],"id":{"isbn":["9783319454573"],"doi":["10.1007/978-3-319-45457-3"],"eki":["1654791407"]},"physDesc":[{"extent":"Online-Ressource (XIV, 238 p. 23 illus., 20 illus. in color, online resource)"}],"title":[{"title":"Biobanking and cryopreservation of stem cells","title_sort":"Biobanking and cryopreservation of stem cells"}]}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"12 November 2016"}],"type":{"bibl":"chapter","media":"Online-Ressource"},"title":[{"title":"Cryopreserved or fresh mesenchymal stromal cells","subtitle":"only a matter of taste or key to unleash the full clinical potential of MSC therapy?","title_sort":"Cryopreserved or fresh mesenchymal stromal cells"}],"id":{"eki":["158761944X"],"doi":["10.1007/978-3-319-45457-3_7"]},"physDesc":[{"extent":"22 S."}],"recId":"158761944X","person":[{"role":"aut","family":"Moll","display":"Moll, Guido","given":"Guido"},{"given":"Karen","display":"Bieback, Karen","role":"aut","family":"Bieback"}],"note":["Gesehen am 13.02.2019","First Online 12 November 2016"],"name":{"displayForm":["Guido Moll, Sven Geißler, Rusan Catar, Lech Ignatowicz, Martin J. Hoogduijn, Dirk Strunk, Karen Bieback, Olle Ringdén"]},"language":["eng"]} 
SRT |a MOLLGUIDOBCRYOPRESER1220